3.3 Risk Disclosures & Accurate Information Relay
Key Takeaways
Persons Associated with Research Services (PARS) are the main communication link with clients, so they must present investment risks as clearly as potential returns.
SEBI requires research analysts to state on reports, correspondence and advertisements that SEBI registration and NISM certification do not guarantee performance or assure returns.
Research reports carry downside risk factors, such as valuation sensitivity, operational headwinds and sector risks, that PARS must never truncate, omit or downplay with clients.
Assured or guaranteed returns are prohibited: SEBI's standardised MITC says an RA cannot guarantee returns, and the advertisement code bans any promise of assured or risk-free return.
SEBI's advertisement code allows research analysts to cite past performance or risk-return metrics only when they are verified by the Past Risk and Return Verification Agency (PaRRVA).
3.3 Risk Disclosures & Accurate Information Relay
Quick Answer: The SEBI (Research Analysts) Regulations, 2014, SEBI's advertisement code and the standardised MITC require honest, balanced communication, so Persons Associated with Research Services (PARS) should present investment risks as clearly as upside potential. Research analysts' target prices are conditional mathematical estimates, not guaranteed outcomes. Promising guaranteed returns, omitting downside risks, or cherry-picking historical winners is strictly illegal under SEBI regulations and the Prohibition of Fraudulent and Unfair Trade Practices (PFUTP) framework.
The Strategic and Regulatory Role of PARS in Risk Communication
In daily operations, frontline professionals—such as business development executives, sales managers, and client relationship associates certified under NISM Series XXV-A—serve as the primary human touchpoint between a research entity and the investing public. While institutional clients employ sophisticated research desks capable of deconstructing complex valuation models, retail subscribers and High Net Worth Individuals (HNIs) rely heavily on PARS to explain published research reports.
Individual investors are naturally prone to return-seeking bias: they fixate on headline numbers such as "35% Potential Upside", "Target Price ₹1,200", or historic track records of multibagger winners, while ignoring or skipping the pages detailing operational, regulatory, and valuation risks.
Under SEBI regulations, a PARS is not an aggressive telemarketer; they are a certified capital market professional working under the RA Regulations and the firm's Code of Conduct. The primary ethical responsibility of a PARS is to act as a counterweight to investor cognitive bias by ensuring that investment risks are communicated with equal prominence, clarity, and seriousness as projected returns.
SEBI Statutory Risk Disclosures & Disclaimers
The RA Regulations (disclosures in Regulations 19 to 22 and the Code of Conduct in the Third Schedule) and SEBI's Master Circular for Research Analysts (February 6, 2026) set the disclosure and display rules for research reports, advertisements, websites and client correspondence.
1. The Standard Warning in Advertisements
SEBI's advertisement code for research analysts requires every advertisement to carry, in legible fonts of at least 10-point size, the standard warning:
"Investment in securities market are subject to market risks. Read all the related documents carefully before investing."
No words may be added to or deleted from this standard warning. It must be translated accurately when the advertisement is in another language, and in audio-visual advertisements it must be both shown and read out clearly. A research report is treated as an advertisement if anything in it promotes the RA's products or services.
2. Mandatory Regulatory Disclaimer on SEBI & NISM Credentials
To prevent intermediaries from misleading unsophisticated investors into believing that government regulatory bodies have validated the profitability of their recommendations, SEBI mandates the inclusion of the following specific disclaimer:
"Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."
The master circular requires this disclaimer on the website, notice boards, display boards, advertisements, publications, KYC forms, client agreements, statements, reports and other correspondence with clients. In advertisements the wording is: "Registration granted by SEBI, enlistment with BSE and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors." An RA must not use the SEBI logo. The disclaimer makes clear that registration and certification are baseline qualifications, not an endorsement of any recommendation.
3. Statutory Entity Identifiers
All published communications distributed by PARS must clearly display the firm's verified regulatory credentials, including:
- Complete legal name of the Research Analyst or Research Entity
- SEBI Registration Number (e.g.,
INH00000XXXX) - Registered office address and Corporate Identity Number (CIN)
- Official corporate website and compliance email address
- Name, direct telephone number, and official email of the Compliance Officer
- Name and contact details of the Grievance Redressal Officer
- Information guiding investors on how to lodge complaints on the SEBI SCORES 2.0 portal (
scores.sebi.gov.in) or invoke the SMART ODR dispute resolution mechanism (smartodr.in).
Decoding and Relaying Risk Factors in Research Reports
Most professional research reports authored by a certified Research Analyst contain a dedicated section titled "Key Investment Risks", "Downside Risks to Target Price", or "Sensitivity Analysis". This section outlines the specific microeconomic, industry, or corporate conditions under which the investment thesis would fail.
Anatomy of Research Downside Risk Factors
- Valuation Sensitivity Risks: Research analysts project target prices using valuation multiples (such as P/E of 22x or EV/EBITDA of 14x) applied to projected earnings. The risk section details how a 100 basis point margin contraction or a de-rating of the sector multiple to 16x would compress the stock's fair value below the current market price.
- Input Cost & Commodity Vulnerability: For manufacturing, automotive, or chemical firms, reports specify sensitivity to raw material price inflation (such as steel, crude oil, or natural gas) that cannot be passed on to end consumers.
- Regulatory & Policy Headwinds: Identifies pending litigation, environmental compliance approvals, price ceiling regulations (such as National Essential Medicines List pricing for pharmaceutical firms), or import/export tariff revisions.
- Customer or Geographic Concentration: Quantifies the risk of high revenue dependency on top clients (e.g., "Top 5 clients contribute 58% of total revenue") or single geographic regions exposed to economic slowdowns.
- Financial Leverage & Refinancing Risks: Details debt maturity schedules, debt covenants, and foreign currency debt exposure vulnerable to Rupee depreciation.
The Operational Duty of PARS: Complete and Unaltered Relay
Clients frequently contact sales or relationship desks asking for a "one-minute WhatsApp summary" or "just the bottom line on this stock."
PARS are strictly prohibited from truncating, editing, or redrafting a research report in a manner that highlights the positive recommendation while concealing or downplaying the identified downside risks.
Warning
Distributing an abridged marketing summary that quotes an analyst's ₹650 target price (a 30% upside from ₹500) while deliberately stripping out the analyst's explicit warning regarding upcoming debt refinancing distress constitutes a fraudulent and deceptive practice under SEBI regulations. The PARS must always distribute the complete, unaltered published research report and verbally highlight the key downside risks when summarizing the thesis to clients.
The Absolute Legal Prohibition on Guaranteed Returns
Under Indian capital markets jurisprudence, the prohibition on assuring or guaranteeing returns is absolute, non-negotiable, and strictly enforced.
Statutory Basis for the Prohibition
- SEBI (Research Analysts) Regulations, 2014 and the RA Master Circular: The Code of Conduct in the Third Schedule requires RAs to act honestly, in good faith and with due diligence. The standardised MITC states that the RA cannot guarantee returns, profits, accuracy or risk-free investments and that assured-return schemes are prohibited by law, and the advertisement code bans any promise of assured or risk-free returns.
- SEBI (Prohibition of Fraudulent and Unfair Trade Practices relating to Securities Market) Regulations, 2003 (PFUTP): Regulation 4(2)(k) and related clauses strictly prohibit intermediaries and market participants from making false, misleading, or deceptive representations, promises, or forecasts regarding securities to induce investors to trade.
Why Equities Inherently Preclude Guarantees
Equities represent residual risk capital. A company's operating profits, cash flows, and market valuations are subject to shifting economic forces, competition, and investor sentiment. Neither corporate dividends nor stock price appreciation are guaranteed by law or contract. Anyone who claims that an equity investment carries "guaranteed 20% annual returns" or "100% risk-free growth" is committing market fraud.
Target Price vs. Guaranteed Return: A Critical Distinction
PARS must be equipped to explain the fundamental distinction between an analyst's target price and a guaranteed return to clients:
| Dimension | Analyst Target Price | Prohibited Guaranteed Return |
|---|---|---|
| Definition | A conditional theoretical fair value estimate derived from quantitative valuation models (DCF, P/E multiples) | A fraudulent commercial promise assuring an investor of a specific financial payoff or profit |
| Time Horizon | Probabilistic forecast typically set over a 12-to-18-month investment window | A rigid promise often tied to arbitrary short-term periods (e.g., "Double in 6 months") |
| Underlying Assumptions | Explicitly contingent upon stated revenue growth, margin forecasts, and macroeconomic stability | Ignores economic realities and asserts certainty where none exists |
| Capital Protection | Acknowledges the reality of capital downside and volatility if assumptions fail | Falsely claims "zero downside" or "guaranteed capital safety" |
| Regulatory Status | Fully permitted and standard practice in legitimate research analysis | Strictly illegal under SEBI RA and PFUTP Regulations |
Important
An oral promise made over a telephone call or an informal message sent over WhatsApp or Telegram carries identical regulatory liability to a printed prospectus. SEBI enforcement tribunals regularly impound illegal subscription fees, issue multi-year market debarments, and impose severe financial penalties on firms and individual personnel who promise guaranteed returns.
Communicating Capital Risk & Eliminating Deceptive Marketing
To uphold market integrity and protect retail investors, PARS must maintain transparent communication standards and eliminate deceptive sales tactics.
1. Transparent Articulation of Capital Risk
When interacting with prospective subscribers, PARS must clearly explain that all investments in equities and securities involve capital risk. Capital risk means that the value of an investor's holding can decline below the original purchase price, resulting in unrealized or realized financial losses. Investors must be informed that neither the research entity, nor SEBI, nor the stock exchanges insure or protect their invested capital against market downturns.
2. Elimination of Cherry-Picking
A common manipulative tactic used by unregistered entities is cherry-picking: showcasing the 2 or 3 research recommendations that achieved spectacular 70% gains over the past quarter, while deliberately concealing the 10 recommendations that hit stop-losses or declined.
SEBI's advertisement code goes further: an RA may not refer to past performance or risk-return metrics of its services unless the metrics are verified by the Past Risk and Return Verification Agency (PaRRVA) and the claims are made in the manner SEBI specifies. Superlatives such as "Best", "No. 1" or "Top Research Analyst" are also banned in advertisements.
3. Prohibition of Superlative & Urgent Sales Language
PARS must never use speculative, exaggerated, or pressure-driven sales pitches. Prohibited language includes:
- "Sure-shot call", "Jackpot stock", "100% confirmed multibagger"
- "Risk-free wealth creation", "Guaranteed capital doubling"
- Inducing artificial FOMO (Fear Of Missing Out): "Buy immediately before the 9:15 AM market open or you will miss the biggest rally of the year!"
4. Operational Best Practices for Frontline PARS
- Stick to Approved Research Collateral: When communicating with clients via email, messaging, or presentations, utilize only compliance-approved summaries that include standard risk disclaimers.
- Maintain Audit Trails: Ensure that all client communications, advisory boundary disclaimers, and research delivery confirmations are logged within the firm's verified Customer Relationship Management (CRM) system.
- Reinforce the Advisory Boundary: If a client asks, "Should I invest my entire ₹10 lakh retirement savings in this stock?", the PARS must immediately decline to answer, clarify that PARS do not provide personalized investment advice under SEBI regulations, and direct the client to an authorized SEBI-registered Investment Adviser (RIA).
During a telephone conversation with a prospective client, a relationship associate working as a PARS at a SEBI-registered research entity states: 'Our flagship Bluechip Research Model is guaranteed to generate a minimum 25% annualized return with zero capital downside over the next 12 months.' How is this statement categorized under SEBI regulations?
It is a standard promotional statement permitted under the SEBI (Research Analysts) Regulations, 2014 provided the research firm has a net worth exceeding ₹1 crore.
It is a severe regulatory violation: SEBI's research analyst framework and the PFUTP Regulations prohibit assuring or guaranteeing returns in securities.
It is fully compliant as long as the research analyst signs an internal memorandum agreeing with the projected 25% target.
It is permissible provided the client signs a digital waiver acknowledging that the guarantee is verbal rather than written.
An institutional research report issues a 'BUY' recommendation for an infrastructure company with a target price of ₹650 (representing a 30% upside from current price ₹500). The report explicitly details two key downside risks: high debt refinancing pressure in Q3 and delays in environmental clearances for a core highway project. When presenting this research to prospective clients, what is the legal obligation of a PARS?
Emphasize only the ₹650 target price and 30% upside to avoid discouraging clients from opening trading accounts.
Advise the client to purchase put options on the infrastructure company to hedge against the research analyst's call.
Provide the complete, unaltered report and explicitly highlight the identified downside risk factors alongside the target price and investment thesis.
Delete the risk factor section from the executive summary to keep the presentation concise and engaging.
Which of the following statements represents the mandatory regulatory disclosure that must be prominently displayed across all research reports and official communications issued by a SEBI-registered Research Analyst?
'Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.'
'SEBI registration certifies that all target prices published by the research entity have been pre-audited and validated for accuracy.'
'NISM certification guarantees that any investment made pursuant to this research report is insured against capital depreciation by the Investor Protection Fund.'
'All securities recommended within this publication are guaranteed to outperform the benchmark NIFTY 50 over a 3-year investment horizon.'
Sections you finish are checked off in the contents.